ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

ELTX Elicio Therapeutics Inc

10,05
0,67 (7,14%)
18 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Elicio Therapeutics Inc ELTX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,67 7,14% 10,05 00:04:46
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
9,96 9,5001 10,38 10,05 9,38
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
15/5/202422:34EDGAR2Form 8-K - Current report
15/5/202422:30GLOBEElicio Therapeutics Reports First Quarter 2024 Financial..
25/4/202414:30GLOBEElicio Therapeutics to Present New Preliminary Data from the..
05/4/202422:30GLOBEElicio Therapeutics to Present Updated Clinical T Cell and..
29/3/202413:30GLOBEElicio Therapeutics Reports 2023 Financial Results and..
18/3/202413:00GLOBEElicio Therapeutics Announces $6.0 Million Private Placement..
05/2/202414:30GLOBEElicio Therapeutics to Present at the Oppenheimer 34th..
25/1/202415:00GLOBEElicio Therapeutics Announces Publication of Preclinical..
17/1/202414:30GLOBEElicio Therapeutics to Present ELI-002 7P (AMPLIFY-7P) Trial..
16/1/202414:30GLOBEElicio Therapeutics to Present at the B. Riley Securities..
11/1/202414:30GLOBEElicio Therapeutics Announces First Patient Dosed in..
09/1/202412:00GLOBENature Medicine Publishes Updated Preliminary Phase 1 Data..
22/12/202315:00GLOBEElicio Therapeutics Announces $7.0 Million Private Placement..
04/12/202314:00GLOBEElicio Therapeutics to Present at the H.C. Wainwright 4th..
09/11/202322:30GLOBEElicio Therapeutics Reports Third Quarter 2023 Financial..
03/11/202321:30GLOBEElicio Therapeutics Presents Updated Preliminary..
11/10/202314:00GLOBEElicio Therapeutics Announces Upcoming Presentations at the..
27/9/202323:30GLOBEElicio Therapeutics Presents Updated Preliminary Data..
07/9/202314:00GLOBEElicio Therapeutics Receives $2.6 Million Grant from the..
06/9/202314:00GLOBEElicio Therapeutics to Present at the H.C. Wainwright 25th..
05/9/202314:00GLOBEElicio Therapeutics to Present Phase 1 Data on Cancer..
28/8/202314:00GLOBEElicio Therapeutics Announces Appointment of Megan Filoon as..
22/8/202322:30GLOBEElicio Therapeutics Reports Inducement Grants
11/8/202314:30GLOBEElicio Therapeutics Reports Second Quarter 2023 Financial..
09/8/202314:00GLOBEElicio Therapeutics Announces Publication of Preclinical..
06/6/202314:00GLOBEElicio Therapeutics Completes Reverse Merger and Provides a..
03/6/202315:00GLOBEElicio Therapeutics Announces Positive Interim Data from the..
02/6/202322:30GLOBEElicio Therapeutics Reports Inducement Grant to New Chief..
01/6/202322:04GLOBEElicio Therapeutics Announces Completion of Merger with..